lactic acid has been researched along with Leishmaniasis in 7 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barros, D | 1 |
| Costa Lima, SA | 1 |
| Cordeiro-da-Silva, A | 1 |
| da Silva Maffei, R | 1 |
| Yokoyama-Yasunaka, JK | 1 |
| Miguel, DC | 1 |
| Uliana, SR | 1 |
| Espósito, BP | 1 |
| Tafaghodi, M | 2 |
| Khamesipour, A | 2 |
| Jaafari, MR | 2 |
| Eskandari, M | 1 |
| Kharazizadeh, M | 1 |
| Sarkar, S | 1 |
| Mandal, S | 1 |
| Sinha, J | 1 |
| Mukhopadhyay, S | 1 |
| Das, N | 1 |
| Basu, MK | 2 |
| Medda, S | 1 |
| Jaisankar, P | 1 |
| Manna, RK | 1 |
| Pal, B | 1 |
| Giri, VS | 1 |
| SILVESTRI, U | 1 |
7 other studies available for lactic acid and Leishmaniasis
| Article | Year |
|---|---|
Surface functionalization of polymeric nanospheres modulates macrophage activation: relevance in leishmaniasis therapy.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cells, Cultured; Cytokines; Drug Carriers; Lactic Aci | 2015 |
Synthesis, characterization and evaluation of antileishmanial activity of copper(II) with fluorinated α-hydroxycarboxylate ligands.
Topics: Antiprotozoal Agents; Cell Culture Techniques; Copper; Dose-Response Relationship, Drug; Electron Sp | 2009 |
Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Cytokines; Disease Models, Animal; Drug Carr | 2011 |
Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Drug Carriers; Drug Delivery Systems; Female | 2010 |
Quercetin: critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes.
Topics: Algorithms; Animals; Antiprotozoal Agents; Capsules; Cricetinae; Lactic Acid; Leishmaniasis; Liposom | 2002 |
Phospholipid microspheres: a novel delivery mode for targeting antileishmanial agent in experimental leishmaniasis.
Topics: Animals; Antiparasitic Agents; Cholesterol; Cricetinae; Dose-Response Relationship, Drug; Indoles; I | 2003 |
[Use of lactate of 2 ethoxy-6,9-diaminoacridine (rivanol) in cutaneous leishmaniasis].
Topics: Acridines; Coloring Agents; Ethacridine; Lactates; Lactic Acid; Leishmaniasis; Leishmaniasis, Cutane | 1951 |